Over a month ago |
Syndicate
|
The deal range was… The deal range was $12.10-$12.30. Goldman Sachs acted as sole book running manager for the offering. ShowHide Related Items >><< - 09/29/22
- Leslie's publishes annual ESG report
- 09/28/22
- Leslie's to replace GCP Applied Technologies in S&P 600 at open on 9/28
- 07/14/22
- Leslie's opened 11 new stores in summer 2022
- 12/01/22 Stifel
- Leslie's downgraded to Hold from Buy at Stifel
- 11/28/22 Stifel
- Leslie's price target lowered to $17 from $20 at Stifel
- 11/15/22 Baird
- Leslie's downgraded to Neutral from Outperform at Baird
- 10/03/22 MKM Partners
- MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability
- 11/30/22
- Leslie's sees 2023 adjusted EPS 78c-86c, consensus 93c
- 11/30/22
- Leslie's reports Q4 adjusted EPS 35c, consensus 31c
- 11/29/22
- Notable companies reporting before tomorrow's open
|
Syndicate
|
Goldman Sachs is acting… Goldman Sachs is acting as sole book running manager for the offering. ShowHide Related Items >><< - 09/29/22
- Leslie's publishes annual ESG report
- 09/28/22
- Leslie's to replace GCP Applied Technologies in S&P 600 at open on 9/28
- 07/14/22
- Leslie's opened 11 new stores in summer 2022
- 12/01/22 Stifel
- Leslie's downgraded to Hold from Buy at Stifel
- 11/28/22 Stifel
- Leslie's price target lowered to $17 from $20 at Stifel
- 11/15/22 Baird
- Leslie's downgraded to Neutral from Outperform at Baird
- 10/03/22 MKM Partners
- MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability
- 11/30/22
- Leslie's sees 2023 adjusted EPS 78c-86c, consensus 93c
- 11/30/22
- Leslie's reports Q4 adjusted EPS 35c, consensus 31c
- 11/29/22
- Notable companies reporting before tomorrow's open
|
Downgrade
|
Stifel analyst W. Andrew… Stifel analyst W. Andrew Carter downgraded Leslie's to Hold from Buy with a price target of $15, down from $17, post the Q4 results and investor day. The outlook concentrating comparable revenue growth in the second half of 2023 following first half declines at best suggests a "wait-and-see" approach, Carter tells investors in a research note. The analyst says he overestimated Leslie's "potential defensibility" amid a softer environment, and that he now approaches the pro strategy with "greater skepticism." ShowHide Related Items >><< - 09/29/22
- Leslie's publishes annual ESG report
- 09/28/22
- Leslie's to replace GCP Applied Technologies in S&P 600 at open on 9/28
- 07/14/22
- Leslie's opened 11 new stores in summer 2022
- 11/28/22 Stifel
- Leslie's price target lowered to $17 from $20 at Stifel
- 11/15/22 Baird
- Leslie's downgraded to Neutral from Outperform at Baird
- 10/03/22 MKM Partners
- MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability
- 10/03/22 MKM Partners
- Leslie's initiated with a Neutral at MKM Partners
- 11/30/22
- Leslie's sees 2023 adjusted EPS 78c-86c, consensus 93c
- 11/30/22
- Leslie's reports Q4 adjusted EPS 35c, consensus 31c
- 11/29/22
- Notable companies reporting before tomorrow's open
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 11/30/22
- XPeng rises 39.9%
- 11/30/22
- XPeng rises 24.8%
- 11/30/22
- XPeng rises 24.3%
- 11/15/22
- Cathie Wood's ARK Investment bought 105K shares of XPeng
- $11.06 /
+1.585 (+16.73%) - 11/30/22
- Petco announces partnership with Stella & Chewy's
- 11/30/22
- Petco jumps 13% to $10.76 after Q3 results, FY22 guidance
- 11/30/22
- Petco reports Q3 comparable sales growth of 4.1%
- 10/27/22
- Petco, Nationwide announce multi-year partnership
- $167.70 /
+24.325 (+16.97%) - 11/29/22
- Workday sees FY24 subscription revenue growth of 17%-19% to $6.5B-$6.6B
- 11/29/22
- Workday jumps 5% to $150.00 after Q3 results beat estimates
- 11/29/22
- Workday reports Q3 subscription revenue $1.43B, up 22.3% y/y
- 11/29/22
- Workday announces $500M share repurchase program
- $217.49 /
+4.625 (+2.17%) - 11/22/22
- STB to hold in-person public hearing with Union Pacific over use of embargoes
- 10/20/22
- UBS, Microsoft announce landmark expansion of cloud partnership
- 10/04/22
- UBS Securities fined $2.5M for regulation SHO violations by FINRA
- 09/27/22
- SEC charges 16 Wall Street firms with recordkeeping failures
- 09/13/22
- UBS plans to raise dividend, extend share buyback
SPY SPDR S&P 500 ETF Trust - 11/14/22
- Jana made new buy Freshpet top holding in Q3, also bought Momentive
- 11/07/22
- SEC Chief Prashant Yerramalli departing Dec. 31, Amanda Fischer to replace
- 06/14/22
- Ackman says 75 point hike tomorrow can help restore confidence in Fed
- 06/07/22
- Global growth to fall to 2.9% in 2022 from 5.7% in 2021, World Bank says
- 11/30/22
- Sanofi reports Phase II/III study results for acoziborole published in Lancet
- 11/17/22
- Provention Bio's Tzield approved by FDA for diabetes
- 11/29/22
- Solid Power CEO Douglas Campbell to retire, David Jensen named interim CEO
- 06/06/22
- Solid Power announces installation of EV cell pilot line
- $32.05 /
+3.195 (+11.07%) - 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 11/13/22
- Fly Intel: Top five weekend stock stories
- 11/09/22
- Rivian Automotive rallies 7% to $30.02 after keeping production outlook
- 11/09/22
- Rivian Automotive expects R2 platform to launch in 2026
- 11/14/22
- Elliott made Triple Flag Precious Metals top holding during Q3
- 10/28/22
- Pinterest rises 14.4%
- 10/27/22
- Pinterest jumps 14% to $24.89 after Q3 results beat estimates
- 10/27/22
- Pinterest sees FY non-GAAP operating expenses up 35% y/y
- 08/08/22
- Nutrien name Ken Seitz as President and CEO
- 07/20/22
- Nutrien to acquire Casa do Adubo, terms undisclosed
- 06/09/22
- Nutrien announces plans to increase fertilizer production capacity
- 11/30/22
- NetApp trading resumes
- 11/30/22
- NetApp trading halted, volatility trading pause
- 11/29/22
- NetApp falls 11% to $64.00 after Q2 results and FY23 guidance cut
- 11/16/22
- NetApp Chief Strategy Officer, Matthew Fawcett, to retire on Feb. 28, 2023
- 11/21/22
- Norfolk Southern to purchase assets of Cincinnati Southern Railway
- 09/29/22
- Leslie's publishes annual ESG report
- 09/28/22
- Leslie's to replace GCP Applied Technologies in S&P 600 at open on 9/28
- 07/14/22
- Leslie's opened 11 new stores in summer 2022
- 11/15/22
- Lucid Group announces new details about Gravity luxury electric SUV
- 11/08/22
- Lucid Group falls 10% to $12.03 after Q3 results
- 11/08/22
- Lucid Group plans to open reservations for Project Gravity SUV in early 2023
- $177.94 /
+1.895 (+1.08%) - 11/30/22
- AC Immune's ACI-35.030 selected for further development
- 11/22/22
- BeiGene to present final PFS results from ALPINE trial at ASH 2022
- 11/21/22
- Intuit, NFL expand official partnership in four-year renewal
- 11/01/22
- Intuit to update Credit Karma guidance on Q1 earnings call
- 09/28/22
- Intuit opens new Canadian headquarters in Toronto
- 09/01/22
- FTC says Intuit's Credit Karma to pay $3M, halt 'deceptive claims'
HZNP Horizon Therapeutics - $100.26 /
+21.51 (+27.31%) - 11/29/22
- Horizon Therapeutics jumps 33% after deal talks with Amgen, Janssen, Sanofi
- 11/29/22
- Horizon Pharma trading resumes
- 11/29/22
- Horizon Therapeutics confirms preliminary deal talks with Amgen, Janssen, Sanofi
- 11/29/22
- Horizon Pharma trading halted, news pending
- 09/12/22
- Oneok names Janet Hogan as Chief Human Resources Officer
- 08/09/22
- Hormel Foods announces new operating model
- 11/08/22
- HP Enterprise, VMware announce next phase of partnership
- 10/19/22
- HP Enterprise sees revenue growth up 2%-4% over the long term
- 09/26/22
- KAUST selects HP Enterprise to build supercomputer in Middle East
- 06/28/22
- HP Enterprise expands portfolio with servers based on cloud-native silicon
- 11/17/22
- Fisker commences production of Fisker Ocean all-electric SUV on schedule
- 09/20/22
- Fisker, Wallbox partner on home EV charging solutions
- 08/12/22
- Fisker sells out of 2023 planned production of two trim levels for U.S. market
- 08/03/22
- Fisker sees FY22 CapEx $280M-$290M
- 11/23/22
- Carvana rises 16.8%
- 11/22/22
- Carvana CPO Gill acquires 133,000 class A shares
- 11/21/22
- Carvana falls -14.1%
- 11/21/22
- Carvana falls -7.0%
- 11/16/22
- North American rail traffic down 2.8% for the week ending November 12
- $117.56 /
-20.62 (-14.92%) - 11/29/22
- Crowdstrike sees Q4 ARR below Q3 levels by up to 10%
- 11/29/22
- Crowdstrike falls 18% after Q3 results and guidance
- 09/20/22
- Crowdstrike to acquire external attack surface management firm Reposify
- 09/14/22
- CrowdStrike Appoints Jennifer Johnson as CMO
- $228.53 /
-10.91 (-4.56%) - 11/30/22
- Charles River trading resumes
- 11/30/22
- Charles River working to mitigate any Cambodia NHP supply impact
- 11/30/22
- Charles River says not named or referenced in DOJ proceedings
- 11/30/22
- Charles River trading halted, news pending
- 11/17/22
- Pershing expects CP, KSU merger to create many growth opportunities
- 08/09/22
- Cooper Companies appoints Nicholas Khadder general counsel
- 11/30/22
- North American rail traffic up 2.4% for the week ending November 26
- 11/29/22
- Rail union BMWED 'disappointed' in Biden proposal not including 'paid sick days'
- 11/28/22
- Canadian National appoints Edmond Harris COO
- 11/23/22
- North American rail traffic up 1.5% for the week ending November 19
- 11/29/22
- Baidu announces plan to build largest autonomous ride-hailing service area
- 08/25/22
- Baidu announces first integrated superconducting quantum computer
- 08/08/22
- Baidu secures first permits in China to offer fully driverless robotaxi services
- 07/21/22
- Baidu unveils Apollo RT6 autonomous vehicle
- 11/14/22
- Greenlight takes new stake in Intel, exits position in Atlas Air
- 11/14/22
- AST SpaceMobile deploys commercial communications array in low Earth orbit
- 10/26/22
- AST SpaceMobile announces BlueWalker 3 test satellite update, Q3 results
- 09/15/22
- AST SpaceMobile down 8% to $9.38 after Kerrisdale release short report
- 11/30/22
- Iceberg Research short American Resources, says 'close to running out of money'
- 11/17/22
- ReElement Technologies appoints Daniel Hasler to board upon spin-off
- 11/10/22
- American Resources' ReElement secures manufacturing readiness grant
- 11/10/22
- American Resources announces $200K state-level grant from Indiana
- 11/22/22
- FDA investigating risk of severe hypocalcemia in patients receiving Prolia
- 11/09/22
- Royalty Pharma agrees to acquire royalty interest in olpasiran from Arrowhead
- 11/16/22
- Airbnb director sells $26.7M in common stock
- 11/01/22
- Airbnb says Nights and Experiences Booked growth to moderate in Q4
- 11/01/22
- Airbnb falls 6% to $102.27 after Q3 results and Q4 guidance
- 09/08/22
- TDCX grants Airbnb warrants to purchase up to 490K American Depositary Shares
- 06/22/22
- President Biden calls on Congress to suspend federal gas tax
- 11/29/22 BofA
- Canadian National price target raised to $140 from $131 at BofA
- 10/26/22 BMO Capital
- Canadian National price target raised to C$180 from C$170 at BMO Capital
- 10/26/22 Scotiabank
- Canadian National price target raised to C$159 from C$156 at Scotiabank
- 10/26/22 Barclays
- Canadian National price target raised to $118 from $110 at Barclays
- 11/28/22 Deutsche Bank
- Deutsche upgrades 'highest quality railroad' Canadian Pacific to Buy
- 11/28/22 Deutsche Bank
- Canadian Pacific upgraded to Buy from Hold at Deutsche Bank
- 10/27/22 Scotiabank
- Canadian Pacific price target raised to C$102 from C$100 at Scotiabank
- 10/27/22 Barclays
- Canadian Pacific price target raised to $81 from $77 at Barclays
- 11/29/22 Barclays
- CSX price target raised to $38 from $35 at Barclays
- 11/28/22 Deutsche Bank
- CSX price target raised to $39 from $36 at Deutsche Bank
- 10/24/22 Deutsche Bank
- CSX price target lowered to $36 from $41 at Deutsche Bank
- 10/14/22 Vertical Research
- CSX upgraded to Buy from Hold at Vertical Research
- 06/27/22 Credit Suisse
- Canadian National initiated with a Neutral at Credit Suisse
- 03/10/22 JPMorgan
- JPMorgan resumes Canadian Pacific at Overweight, adds to Focus List
- 12/20/21 Evercore ISI
- Canadian Pacific resumed at Outperform from In Line at Evercore ISI
- 11/29/22 Citi
- Norfolk Southern price target raised to $250 from $225 at Citi
- 11/28/22 Deutsche Bank
- Norfolk Southern price target raised to $273 from $220 at Deutsche Bank
- 11/17/22 Wolfe Research
- Wolfe reshuffles ratings in freight with five downgrades and one upgrade
- 11/17/22 Wolfe Research
- Norfolk Southern downgraded to Peer Perform from Outperform at Wolfe Research
- $217.49 /
+4.625 (+2.17%) - 11/28/22 Deutsche Bank
- Union Pacific price target raised to $238 from $216 at Deutsche Bank
- 11/01/22 RBC Capital
- Union Pacific cut to Underperform at RBC Capital on weak operating performance
- 11/01/22 RBC Capital
- Union Pacific downgraded to Underperform from Sector Perform at RBC Capital
- 10/24/22 Deutsche Bank
- Union Pacific price target lowered to $216 from $232 at Deutsche Bank
- 11/30/22 Susquehanna
- HP Enterprise price target raised to $16 from $15 at Susquehanna
- 11/30/22 Deutsche Bank
- HP Enterprise price target raised to $16 from $15 at Deutsche Bank
- 11/30/22 Morgan Stanley
- HP Enterprise price target raised to $13 from $12 at Morgan Stanley
- 11/30/22 Citi
- HP Enterprise price target raised to $13 from $11.50 at Citi
HZNP Horizon Therapeutics - $100.26 /
+21.51 (+27.31%) - 11/30/22 Cowen
- Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
- 11/30/22 Wells Fargo
- Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
- 11/01/22 H.C. Wainwright
- Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
- 10/25/22 Piper Sandler
- Horizon Therapeutics price target lowered to $88 from $90 at Piper Sandler
- 11/17/22 Credit Suisse
- Amgen initiated with an Underperform at Credit Suisse
- 11/08/22 Oppenheimer
- Amgen price target raised to $300 from $290 at Oppenheimer
- 11/08/22 Truist
- Amgen price target raised to $280 from $266 at Truist
- $177.94 /
+1.895 (+1.08%) - 11/29/22 Craig-Hallum
- Craig-Hallum sees potential for competing Apollo Endosurgery bids
- 11/28/22 Morgan Stanley
- Genmab risk/reward favorable into arbitration ruling, says Morgan Stanley
- 11/17/22 Credit Suisse
- Johnson & Johnson initiated with a Neutral at Credit Suisse
- 11/14/22 Oppenheimer
- Biogen price target raised to $315 from $300 at Oppenheimer
- 10/14/22 Barclays
- Sanofi price target lowered to EUR 85 from EUR 105 at Barclays
- 10/06/22 Jefferies
- Provention Bio price target raised to $15 from $10 at Jefferies
- 12/01/22 Citi
- Intuit price target lowered to $462 from $498 at Citi
- 11/30/22 Oppenheimer
- Intuit price target lowered to $476 from $516 at Oppenheimer
- 11/30/22 Wells Fargo
- Intuit price target lowered to $475 from $525 at Wells Fargo
- 11/30/22 Deutsche Bank
- Intuit price target lowered to $525 from $560 at Deutsche Bank
- 09/22/22 Argus
- Hormel Foods price target lowered to $53 from $54 at Argus
- 09/02/22 Piper Sandler
- Hormel Foods price target lowered to $47 from $48 at Piper Sandler
- 08/23/22 Stephens
- Hormel Foods price target raised to $55 from $50 at Stephens
- 03/15/22 Goldman Sachs
- Hormel Foods downgraded to Sell from Neutral at Goldman Sachs
- 10/31/22 JPMorgan
- Central bank tightening has likely peaked, says JPMorgan
- 10/07/22 JPMorgan
- JPMorgan changes November rate hike assumption after jobs data
- 09/26/22 JPMorgan
- JPMorgan says stocks oversold amid 'encouraging' inflation signs
- 09/23/22 Goldman Sachs
- Goldman Sachs lowers S&P 500 year-end target to 3,600
SPY SPDR S&P 500 ETF Trust - $117.56 /
-20.62 (-14.92%) - 12/01/22 Redburn
- Crowdstrike initiated with a Buy at Redburn
- 12/01/22 Wolfe Research
- Crowdstrike downgraded to Peer Perform from Outperform at Wolfe Research
- 11/30/22 Truist
- Crowdstrike price target lowered to $200 from $275 at Truist
- 11/30/22 RBC Capital
- Crowdstrike price target lowered to $165 from $200 at RBC Capital
- 11/29/22 Evercore ISI
- Fisker initiated with an Outperform, $15 price target at Evercore ISI
- 11/29/22 Evercore ISI
- Fisker initiated with an Outperform at Evercore ISI
- 11/03/22 RBC Capital
- Fisker cut to Sector Perform at RBC Capital amid growing execution risk
- 11/03/22 RBC Capital
- Fisker downgraded to Sector Perform from Outperform at RBC Capital
- $32.05 /
+3.195 (+11.07%) - 11/29/22 Evercore ISI
- Rivian Automotive initiated with an In Line, $35 target at Evercore ISI
- 11/29/22 Evercore ISI
- Rivian Automotive initiated with an In Line at Evercore ISI
- 11/10/22 RBC Capital
- Rivian Automotive price target lowered to $50 from $61 at RBC Capital
- 11/10/22 Deutsche Bank
- Rivian Automotive price target lowered to $43 from $44 at Deutsche Bank
- 11/29/22 Evercore ISI
- Lucid Group initiated with an In Line, $12 price target at Evercore ISI
- 11/29/22 Evercore ISI
- Lucid Group initiated with an In Line at Evercore ISI
- 11/10/22 R.F. Lafferty
- Lucid Group price target lowered to $17 from $19 at R.F. Lafferty
- 09/27/22 Cantor Fitzgerald
- Lucid Group initiated with an Overweight at Cantor Fitzgerald
- 11/30/22 Baird
- Cooper Companies upgraded to Outperform from Neutral at Baird
- 11/28/22 JPMorgan
- Cooper Companies price target raised to $330 from $300 at JPMorgan
- 11/03/22 Piper Sandler
- Cooper Companies price target lowered to $355 from $375 at Piper Sandler
- 10/11/22 Jefferies
- Cooper Companies downgraded to Hold from Buy at Jefferies
- 11/30/22 BofA
- BofA downgrades Carvana to Neutral on liquidity concerns
- 11/30/22 BofA
- Carvana downgraded to Neutral from Buy at BofA
- 11/22/22 Baird
- Carvana downgraded to Neutral from Outperform at Baird
- 11/21/22 Cowen
- Carvana downgraded to Market Perform from Outperform at Cowen
- 11/29/22 Piper Sandler
- Nutrien downgraded to Neutral from Overweight at Piper Sandler
- 11/17/22 Barclays
- Nutrien price target lowered to $95 from $105 at Barclays
- 11/03/22 Morgan Stanley
- Morgan Stanley expects negative response to Nutrien results and buyback delay
- 11/03/22 Scotiabank
- Nutrien downgraded to Sector Perform from Outperform at Scotiabank
- 10/26/22 JPMorgan
- UBS price target raised to CHF 20.70 from CHF 20 at JPMorgan
- 10/26/22 Deutsche Bank
- UBS price target raised to CHF 22 from CHF 21 at Deutsche Bank
- 10/26/22 RBC Capital
- UBS price target raised to CHF 20 from CHF 19 at RBC Capital
- 10/26/22 Morgan Stanley
- UBS price target raised to CHF 20 from CHF 18.50 at Morgan Stanley
- 11/22/22 Barclays
- Airbnb price target raised to $103 from $101 at Barclays
- 11/22/22 Baird
- Airbnb downgraded to Neutral from Outperform at Baird
- 11/17/22 Citi
- Airbnb supply growth should continue to ramp, says Citi
- 11/02/22 Evercore ISI
- Airbnb removed for 'TAP Outperform' list at Evercore ISI
- 10/31/22 Citi
- Pinterest price target raised to $26 from $25 at Citi
- 10/28/22 Stifel
- Pinterest 'a rare bright spot thus far through earnings,' says Stifel
- 10/28/22 Barclays
- Pinterest price target raised to $25 from $23 at Barclays
- 10/28/22 Piper Sandler
- Pinterest price target raised to $25 from $23 at Piper Sandler
- 11/28/22 Jefferies
- XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
- 11/28/22 Jefferies
- XPeng downgraded to Underperform from Hold at Jefferies
- 11/22/22 DBS Bank
- XPeng initiated with a Buy at DBS Bank (earlier)
- 11/17/22 UBS
- XPeng upgraded to Buy from Neutral at UBS
- 11/23/22 Morgan Stanley
- Baidu price target lowered to $120 from $140 at Morgan Stanley
- 11/23/22 Benchmark
- Baidu price target lowered to $200 from $270 at Benchmark
- 11/23/22 Mizuho
- Baidu price target lowered to $180 from $200 at Mizuho
- 11/23/22 Citi
- Baidu price target lowered to $166 from $169 at Citi
- 11/30/22 DA Davidson
- Solid Power cut to Neutral at DA Davidson on sudden announcement of CEO retiring
- 11/30/22 DA Davidson
- Solid Power downgraded to Neutral from Buy at DA Davidson
- 10/31/22 Cowen
- Solid Power initiated with a Market Perform at Cowen
- 06/29/22 Chardan
- Solid Power initiated with a Buy at Chardan
- 11/23/22 Deutsche Bank
- AST SpaceMobile price target raised to $32 from $30 at Deutsche Bank
- 10/28/22 B. Riley
- AST SpaceMobile initiated with a Buy at B. Riley
- 10/19/22 Barclays
- AST SpaceMobile price target lowered to $15 from $29 at Barclays
- 08/17/22 Deutsche Bank
- AST SpaceMobile price target lowered to $30 from $31 at Deutsche Bank
- 11/30/22 Northland
- NetApp price target lowered to $99 from $101 at Northland
- 11/30/22 Wells Fargo
- NetApp price target lowered to $70 from $85 at Wells Fargo
- 11/30/22 Cowen
- NetApp price target lowered to $80 from $93 at Cowen
- 11/30/22 Wedbush
- NetApp price target lowered to $70 from $80 at Wedbush
- $167.70 /
+24.325 (+16.97%) - 11/30/22 Deutsche Bank
- Workday price target lowered to $215 from $230 at Deutsche Bank
- 11/30/22 Baird
- Workday price target lowered to $223 from $235 at Baird
- 11/30/22 JPMorgan
- Workday price target lowered to $223 from $235 at JPMorgan
- 11/30/22 Mizuho
- Workday price target lowered to $200 from $220 at Mizuho
- 12/01/22 Stifel
- Leslie's downgraded to Hold from Buy at Stifel
- 11/28/22 Stifel
- Leslie's price target lowered to $17 from $20 at Stifel
- 11/15/22 Baird
- Leslie's downgraded to Neutral from Outperform at Baird
- 10/03/22 MKM Partners
- MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability
- $11.06 /
+1.585 (+16.73%) - 12/01/22 UBS
- Petco price target lowered to $12 from $16 at UBS
- 11/30/22 Baird
- Petco price target lowered to $14 from $18 at Baird
- 11/28/22 Wedbush
- Black Friday winners Include Best Buy, losers include Pets, says Wedbush
- 11/28/22 Needham
- Petco price target lowered to $20 from $30 at Needham
- $228.53 /
-10.91 (-4.56%) - 11/30/22 Wells Fargo
- Bust of smuggling ring likely to beheadwind for LabCorp, says Wells Fargo
- 11/03/22 Credit Suisse
- Charles River price target lowered to $280 from $285 at Credit Suisse
- 09/30/22 Jefferies
- Charles River upgraded to Buy at Jefferies on nonhuman primate tailwinds
- 09/29/22 Jefferies
- Charles River upgraded to Buy from Hold at Jefferies
- 11/30/22
- XPeng sees Q4 revenue RMB 4.8B-RMB 5.1B
- 11/30/22
- XPeng reports Q3 EPS (36c), consensus (36c)
- 08/23/22
- XPeng sees Q3 revenue RMB6.8B-RMB7.2B, up 18.9%-25.9% from last year
- 08/23/22
- XPeng reports Q2 no-GAAP EPS (43c), consensus ($2.61)
- $11.06 /
+1.585 (+16.73%) - 11/30/22
- Petco cuts FY22 adjusted EPS view to 75c-79c from 77c-81, consensus 77c
- 11/30/22
- Petco reports Q3 adjusted EPS 16c, consensus 16c
- $167.70 /
+24.325 (+16.97%) - 11/29/22
- Workday raises low end of FY23 subscription revenue to $5.555B-$5.557B
- 11/29/22
- Workday reports Q3 adjusted EPS 99c, consensus 84c
- 08/25/22
- Workday still sees FY23 suscription revenue up 22% y-o-y to $5.54B-$5.56B
- $217.49 /
+4.625 (+2.17%) - 10/20/22
- Union Pacific reports Q3 EPS $3.19, consensus $3.06
- 07/21/22
- Union Pacific reports Q2 EPS $2.93, consensus $2.86
- 10/25/22
- UBS reports Q3 EPS 52c, net profit $1.7B
- 07/26/22
- UBS reports Q2 EPS 61c, net profit $2.108B
- 10/28/22
- Sanofi now sees 2022 business EPS growing 16% at CER
- 10/28/22
- Sanofi reports Q3 business EPS EUR 2.88, up 17.9% at CER
- 07/28/22
- Sanofi sees 2022 business EPS growing 15% at CER
- 07/28/22
- Sanofi reports Q2 business EPS EUR 1.73, up 16.7% at CER
- 08/09/22
- Solid Power sees FY22 revenue at high end of $3M-$5M range, consensus $4.55M
- 08/09/22
- Solid Power reports Q2 EPS 8c, consensus (9c)
- $32.05 /
+3.195 (+11.07%) - 11/09/22
- Rivian Automotive reports Q3 adjusted EPS ($1.57), consensus ($1.82)
- 11/09/22
- Notable companies reporting after market close
- 10/27/22
- Amazon reports Q3 EPS 28c with Rivian gain, consensus 21c
- 08/11/22
- Rivian Automotive reports Q2 EPS ($1.89), consensus ($1.67)
- 10/27/22
- Pinterest sees Q4 revenue up mid single digits, consensus $884.57M
- 10/27/22
- Pinterest reports Q3 adjusted EPS 11c, consensus 6c
- 10/27/22
- Notable companies reporting after market close
- 08/01/22
- Pinterest sees Q3 revenue growth mid-single digits, consensus $713.47M
- 11/02/22
- Nutrien reports Q3 EPS $2.51, consensus $3.97
- 08/03/22
- Nutrien cuts FY22 EPS view to $15.80-$17.80 from $16.20-$18.70
- 08/03/22
- Nutrien reports Q2 EPS $6.51, consensus $5.76
- 11/29/22
- NetApp cuts FY23 EPS view to $5.30-$5.50 from $5.40-$5.60, consensus $5.52
- 11/29/22
- NetApp sees Q3 adjusted EPS $1.25-$1.35, consensus $1.44
- 11/29/22
- NetApp reports Q2 adjusted EPS $1.48, consensus $1.33
- 10/26/22
- Norfolk Southern reports Q3 EPS $4.10, consensus $3.64
- 07/27/22
- Norfolk Southern reports Q2 EPS $3.45, consensus $3.47
- 11/30/22
- Leslie's sees 2023 adjusted EPS 78c-86c, consensus 93c
- 11/30/22
- Leslie's reports Q4 adjusted EPS 35c, consensus 31c
- 11/08/22
- Lucid Group reports Q3 EPS (40c), consensus (31c)
- 11/08/22
- Notable companies reporting after market close
- 08/03/22
- Lucid Group reports Q2 EPS (33c), consensus (36c)
- $177.94 /
+1.895 (+1.08%) - 10/18/22
- Johnson & Johnson cuts FY22 estimated reported sales view to $93.0B-$93.5B
- 10/18/22
- Johnson & Johnson narrows FY22 adjusted operational EPS view to $10.70-$10.75
- 10/18/22
- Johnson & Johnson narrows FY22 adjusted EPS view to $10.02-$10.07
- 10/18/22
- Johnson & Johnson reports Q3 adjusted EPS $2.55, consensus $2.48
- 11/29/22
- Intuit sees Q2 adjusted EPS $1.41-$1.45, consensus $2.06
- 11/29/22
- Intuit backs FY23 adjusted EPS view $13.59-$13.89, consensus $13.75
- 11/29/22
- Intuit reports Q1 adjusted EPS $1.66, consensus $1.22
HZNP Horizon Therapeutics - $100.26 /
+21.51 (+27.31%) - 11/02/22
- Horizon Therapeutics sees FY22 revenue s $3.59B-$3.61B, consensus $3.56B
- 11/02/22
- Horizon Therapeutics reports Q3 EPS $1.25, consensus $1.01
- 08/03/22
- Horizon Therapeutics cuts FY22 revenue view to $3.53B-$3.6B from $3.9B-$4B
- 08/03/22
- Horizon Therapeutics reports Q2 adjusted EPS $1.07, consensus $1.35
- 11/30/22
- Hormel Foods sees FY23 EPS $1.83-$1.93, consensus $2.00
- 11/30/22
- Hormel Foods reports Q4 EPS 51c, consensus 50c
- 11/29/22
- Notable companies reporting before tomorrow's open
- 11/29/22
- HP Enterprise backs FY23 EPS view $1.96-$2.04, consensus $2.03
- 11/29/22
- HP Enterprise sees Q1 adjusted EPS 50c-58c, consensus 49c
- 11/29/22
- HP Enterprise reports Q4 adjusted EPS 57c, consensus 56c
- 11/29/22
- Notable companies reporting after market close
- 11/02/22
- Fisker reports Q3 EPS (49c), consensus (43c)
- 08/03/22
- Fisker reports Q2 EPS (36c), consensus (41c)
- 08/03/22
- Notable companies reporting after market close
- 11/03/22
- Carvana sees sequential reduction in retail units sold in Q4
- 11/03/22
- Carvana reports Q3 EPS ($2.67), consensus ($1.94)
- 08/04/22
- Carvana reports Q2 EPS ($2.35), consensus ($1.79)
- 10/20/22
- CSX reports Q3 EPS 52c, consensus 49c
- 07/20/22
- CSX reports Q2 EPS 54c, consensus 47c
- $117.56 /
-20.62 (-14.92%) - 11/29/22
- Crowdstrike raises FY23 EPS view to $1.49-$1.52 from $1.31-$1.33
- 11/29/22
- Crowdstrike sees Q4 adjusted EPS 42c-45c, consensus 34c
- 11/29/22
- Crowdstrike reports Q3 adjusted EPS 40c, consensus 31c
- $228.53 /
-10.91 (-4.56%) - 11/02/22
- Charles River sees Q4 adjusted EPS $2.65-$2.80, consensus $2.73
- 11/02/22
- Charles River narrows FY22 adjusted EPS view to $10.80-$10.95, consensus $10.80
- 11/02/22
- Charles River reports Q3 adjusted EPS $2.63, consensus $2.49
- 08/03/22
- Charles River sees Q3 adjusted EPS down in high single digits vs. 3Q21
- 10/26/22
- Canadian Pacific reports Q3 adjusted EPS C$0.97 vs C$0.88 last year
- 07/28/22
- Canadian Pacific reports Q2 adjusted EPS C$0.95, down 8% y/y
- 08/31/22
- Cooper Companies sees Q4 revenue $830M - $850M, consensus $841.43M
- 08/31/22
- Cooper Companies sees Q EPS12.72 - $12.87 , consensus $13.14
- 08/31/22
- Cooper Companies sees Q4 EPS $3.05-$3.20, consensus $3.42
- 08/31/22
- Cooper Companies reports Q3 EPS $3.19, consensus $3.23
- 10/25/22
- Canadian National raises FY22 adjusted EPS view to up 25% from up 15%-20%
- 10/25/22
- Canadian National reports Q3 adjusted EPS C$2.13 vs. C$2.37 last year
- 07/26/22
- Canadian National sees FY22 adjusted diluted EPS growth of 15%-20%
- 07/26/22
- Canadian National reports Q2 EPS C$1.93, consensus C$1.76
- 11/22/22
- Baidu reports Q3 EPS $2.37, consensus $2.15
- 08/30/22
- Baidu reports Q2 EPS $2.36, consensus $1.63
- 08/29/22
- Notable companies reporting before tomorrow's open
- 08/15/22
- AST SpaceMobile reports Q2 EPS (6c) vs. (39c) last year
- 07/19/22
- American Resources reports preliminary Q2 revenue $16.2M vs. $393,210 last year
- 11/03/22
- Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00
- 11/03/22
- Amgen reports Q3 adjusted EPS $4.70, consensus $4.44
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.40
- 11/01/22
- Airbnb sees Q4 revenue $1.8B-$1.88B, consensus $1.85B
- 11/01/22
- Airbnb reports Q3 EPS $1.79, consensus $1.47
- 11/01/22
- Notable companies reporting after market close
- 08/02/22
- Airbnb sees Q3 revenue $2.78B-$2.88B, consensus $2.77B
- 06/14/22
- Ackman says 100 point hike tomorrow 'would be better' than 75
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 11/30/22
- XPeng rises 39.9%
- 11/30/22
- XPeng rises 24.8%
- 11/30/22
- XPeng rises 24.3%
- 11/15/22
- Cathie Wood's ARK Investment bought 105K shares of XPeng
- $10.72 /
+1.245 (+13.14%) - 11/30/22
- Petco announces partnership with Stella & Chewy's
- 11/30/22
- Petco jumps 13% to $10.76 after Q3 results, FY22 guidance
- 11/30/22
- Petco reports Q3 comparable sales growth of 4.1%
- 10/27/22
- Petco, Nationwide announce multi-year partnership
- $160.55 /
+17.18 (+11.98%) - 11/29/22
- Workday sees FY24 subscription revenue growth of 17%-19% to $6.5B-$6.6B
- 11/29/22
- Workday jumps 5% to $150.00 after Q3 results beat estimates
- 11/29/22
- Workday reports Q3 subscription revenue $1.43B, up 22.3% y/y
- 11/29/22
- Workday announces $500M share repurchase program
- 10/20/22
- UBS, Microsoft announce landmark expansion of cloud partnership
- 10/04/22
- UBS Securities fined $2.5M for regulation SHO violations by FINRA
- 09/27/22
- SEC charges 16 Wall Street firms with recordkeeping failures
- 09/13/22
- UBS plans to raise dividend, extend share buyback
- 11/22/22
- EC Chief von der Leyen, confirms TikTok's data transfers being investigated
- 11/13/22
- Musk says Twitter Blue 'probably' coming back end of next week
- 11/30/22
- Sanofi reports Phase II/III study results for acoziborole published in Lancet
- 11/17/22
- Provention Bio's Tzield approved by FDA for diabetes
- 11/29/22
- Solid Power CEO Douglas Campbell to retire, David Jensen named interim CEO
- 06/06/22
- Solid Power announces installation of EV cell pilot line
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 11/13/22
- Fly Intel: Top five weekend stock stories
- 11/09/22
- Rivian Automotive rallies 7% to $30.02 after keeping production outlook
- 11/09/22
- Rivian Automotive expects R2 platform to launch in 2026
- 11/14/22
- Elliott made Triple Flag Precious Metals top holding during Q3
- 10/28/22
- Pinterest rises 14.4%
- 10/27/22
- Pinterest jumps 14% to $24.89 after Q3 results beat estimates
- 10/27/22
- Pinterest sees FY non-GAAP operating expenses up 35% y/y
- 11/30/22
- NetApp trading resumes
- 11/30/22
- NetApp trading halted, volatility trading pause
- 11/29/22
- NetApp falls 11% to $64.00 after Q2 results and FY23 guidance cut
- 11/16/22
- NetApp Chief Strategy Officer, Matthew Fawcett, to retire on Feb. 28, 2023
- 11/29/22
- Micron CFO says pricing has trended 'well below' expectations
- 11/16/22
- Micron down 5% after warning outlook for 2023 has weakened
- 11/16/22
- Micron announces further actions to address market conditions
- 11/14/22
- Appaloosa exits positions in Kohl's, Occidental Petroleum, Micron
- 09/29/22
- Leslie's publishes annual ESG report
- 09/28/22
- Leslie's to replace GCP Applied Technologies in S&P 600 at open on 9/28
- 07/14/22
- Leslie's opened 11 new stores in summer 2022
- 11/15/22
- Lucid Group announces new details about Gravity luxury electric SUV
- 11/08/22
- Lucid Group falls 10% to $12.03 after Q3 results
- 11/08/22
- Lucid Group plans to open reservations for Project Gravity SUV in early 2023
- 11/30/22
- AC Immune's ACI-35.030 selected for further development
- 11/22/22
- BeiGene to present final PFS results from ALPINE trial at ASH 2022
- $394.43 /
+13.31 (+3.49%) - 11/21/22
- Intuit, NFL expand official partnership in four-year renewal
- 11/01/22
- Intuit to update Credit Karma guidance on Q1 earnings call
- 09/28/22
- Intuit opens new Canadian headquarters in Toronto
- 09/01/22
- FTC says Intuit's Credit Karma to pay $3M, halt 'deceptive claims'
HZNP Horizon Therapeutics - $99.90 /
+21.15 (+26.86%) - 11/29/22
- Horizon Therapeutics jumps 33% after deal talks with Amgen, Janssen, Sanofi
- 11/29/22
- Horizon Pharma trading resumes
- 11/29/22
- Horizon Therapeutics confirms preliminary deal talks with Amgen, Janssen, Sanofi
- 11/29/22
- Horizon Pharma trading halted, news pending
- 09/12/22
- Oneok names Janet Hogan as Chief Human Resources Officer
- 08/09/22
- Hormel Foods announces new operating model
- 11/08/22
- HP Enterprise, VMware announce next phase of partnership
- 10/19/22
- HP Enterprise sees revenue growth up 2%-4% over the long term
- 09/26/22
- KAUST selects HP Enterprise to build supercomputer in Middle East
- 06/28/22
- HP Enterprise expands portfolio with servers based on cloud-native silicon
- 11/17/22
- Fisker commences production of Fisker Ocean all-electric SUV on schedule
- 09/20/22
- Fisker, Wallbox partner on home EV charging solutions
- 08/12/22
- Fisker sells out of 2023 planned production of two trim levels for U.S. market
- 08/03/22
- Fisker sees FY22 CapEx $280M-$290M
- 11/23/22
- Carvana rises 16.8%
- 11/22/22
- Carvana CPO Gill acquires 133,000 class A shares
- 11/21/22
- Carvana falls -14.1%
- 11/21/22
- Carvana falls -7.0%
- $111.07 /
-27.11 (-19.62%) - 11/29/22
- Crowdstrike sees Q4 ARR below Q3 levels by up to 10%
- 11/29/22
- Crowdstrike falls 18% after Q3 results and guidance
- 09/20/22
- Crowdstrike to acquire external attack surface management firm Reposify
- 09/14/22
- CrowdStrike Appoints Jennifer Johnson as CMO
- 08/09/22
- Cooper Companies appoints Nicholas Khadder general counsel
- 11/29/22
- Baidu announces plan to build largest autonomous ride-hailing service area
- 08/25/22
- Baidu announces first integrated superconducting quantum computer
- 08/08/22
- Baidu secures first permits in China to offer fully driverless robotaxi services
- 07/21/22
- Baidu unveils Apollo RT6 autonomous vehicle
- 11/30/22
- Build-A-Bear rises 15.6%
- 11/30/22
- Build-A-Bear rises 14.3%
- 09/28/22
- Build-A-Bear announces release of NFT collection
- 07/26/22
- Cannell Capital discloses 10.7% activist stake in Build-A-Bear
- 11/14/22
- Greenlight takes new stake in Intel, exits position in Atlas Air
- 11/14/22
- AST SpaceMobile deploys commercial communications array in low Earth orbit
- 10/26/22
- AST SpaceMobile announces BlueWalker 3 test satellite update, Q3 results
- 09/15/22
- AST SpaceMobile down 8% to $9.38 after Kerrisdale release short report
- 11/30/22
- Iceberg Research short American Resources, says 'close to running out of money'
- 11/17/22
- ReElement Technologies appoints Daniel Hasler to board upon spin-off
- 11/10/22
- American Resources' ReElement secures manufacturing readiness grant
- 11/10/22
- American Resources announces $200K state-level grant from Indiana
- 11/22/22
- FDA investigating risk of severe hypocalcemia in patients receiving Prolia
- 11/09/22
- Royalty Pharma agrees to acquire royalty interest in olpasiran from Arrowhead
- 11/16/22
- Airbnb director sells $26.7M in common stock
- 11/01/22
- Airbnb says Nights and Experiences Booked growth to moderate in Q4
- 11/01/22
- Airbnb falls 6% to $102.27 after Q3 results and Q4 guidance
- 09/08/22
- TDCX grants Airbnb warrants to purchase up to 490K American Depositary Shares
- 11/28/22
- Musk says Apple 'threatened to withhold Twitter' from App Store
- 11/23/22
- Apple exec sells $3.0M in common stock
- 11/22/22
- U.K.'s CMA launches probe into cloud gaming, mobile browsers
- 11/20/22
- Fly Intel: Top five weekend stock stories
- $111.07 /
-27.11 (-19.62%) - 11/30/22 Truist
- Crowdstrike price target lowered to $200 from $275 at Truist
- 11/30/22 RBC Capital
- Crowdstrike price target lowered to $165 from $200 at RBC Capital
- 11/30/22 Needham
- Crowdstrike price target lowered to $165 from $225 at Needham
- 11/30/22 DA Davidson
- Crowdstrike price target lowered to $145 from $235 at DA Davidson
- 11/29/22 Evercore ISI
- Fisker initiated with an Outperform, $15 price target at Evercore ISI
- 11/29/22 Evercore ISI
- Fisker initiated with an Outperform at Evercore ISI
- 11/03/22 RBC Capital
- Fisker cut to Sector Perform at RBC Capital amid growing execution risk
- 11/03/22 RBC Capital
- Fisker downgraded to Sector Perform from Outperform at RBC Capital
- 11/29/22 Evercore ISI
- Rivian Automotive initiated with an In Line, $35 target at Evercore ISI
- 11/29/22 Evercore ISI
- Rivian Automotive initiated with an In Line at Evercore ISI
- 11/10/22 RBC Capital
- Rivian Automotive price target lowered to $50 from $61 at RBC Capital
- 11/10/22 Deutsche Bank
- Rivian Automotive price target lowered to $43 from $44 at Deutsche Bank
- 11/29/22 Evercore ISI
- Lucid Group initiated with an In Line, $12 price target at Evercore ISI
- 11/29/22 Evercore ISI
- Lucid Group initiated with an In Line at Evercore ISI
- 11/10/22 R.F. Lafferty
- Lucid Group price target lowered to $17 from $19 at R.F. Lafferty
- 09/27/22 Cantor Fitzgerald
- Lucid Group initiated with an Overweight at Cantor Fitzgerald
- 11/30/22 Susquehanna
- HP Enterprise price target raised to $16 from $15 at Susquehanna
- 11/30/22 Deutsche Bank
- HP Enterprise price target raised to $16 from $15 at Deutsche Bank
- 11/30/22 Morgan Stanley
- HP Enterprise price target raised to $13 from $12 at Morgan Stanley
- 11/30/22 Citi
- HP Enterprise price target raised to $13 from $11.50 at Citi
HZNP Horizon Therapeutics - $99.90 /
+21.15 (+26.86%) - 11/30/22 Cowen
- Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
- 11/30/22 Wells Fargo
- Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
- 11/01/22 H.C. Wainwright
- Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
- 10/25/22 Piper Sandler
- Horizon Therapeutics price target lowered to $88 from $90 at Piper Sandler
- 11/17/22 Credit Suisse
- Amgen initiated with an Underperform at Credit Suisse
- 11/08/22 Oppenheimer
- Amgen price target raised to $300 from $290 at Oppenheimer
- 11/08/22 Truist
- Amgen price target raised to $280 from $266 at Truist
- 11/29/22 Craig-Hallum
- Craig-Hallum sees potential for competing Apollo Endosurgery bids
- 11/28/22 Morgan Stanley
- Genmab risk/reward favorable into arbitration ruling, says Morgan Stanley
- 11/17/22 Credit Suisse
- Johnson & Johnson initiated with a Neutral at Credit Suisse
- 11/14/22 Oppenheimer
- Biogen price target raised to $315 from $300 at Oppenheimer
- 10/14/22 Barclays
- Sanofi price target lowered to EUR 85 from EUR 105 at Barclays
- 10/06/22 Jefferies
- Provention Bio price target raised to $15 from $10 at Jefferies
- $394.43 /
+13.31 (+3.49%) - 11/30/22 Oppenheimer
- Intuit price target lowered to $476 from $516 at Oppenheimer
- 11/30/22 Wells Fargo
- Intuit price target lowered to $475 from $525 at Wells Fargo
- 11/30/22 Deutsche Bank
- Intuit price target lowered to $525 from $560 at Deutsche Bank
- 11/30/22 BofA
- Intuit price target lowered to $475 from $500 at BofA
- 09/22/22 Argus
- Hormel Foods price target lowered to $53 from $54 at Argus
- 09/02/22 Piper Sandler
- Hormel Foods price target lowered to $47 from $48 at Piper Sandler
- 08/23/22 Stephens
- Hormel Foods price target raised to $55 from $50 at Stephens
- 03/15/22 Goldman Sachs
- Hormel Foods downgraded to Sell from Neutral at Goldman Sachs
- 10/26/22 JPMorgan
- UBS price target raised to CHF 20.70 from CHF 20 at JPMorgan
- 10/26/22 Deutsche Bank
- UBS price target raised to CHF 22 from CHF 21 at Deutsche Bank
- 10/26/22 RBC Capital
- UBS price target raised to CHF 20 from CHF 19 at RBC Capital
- 10/26/22 Morgan Stanley
- UBS price target raised to CHF 20 from CHF 18.50 at Morgan Stanley
- 11/30/22 Wedbush
- China lockdown ends in iPhone city, heavy lifting ahead for Apple, says Wedbush
- 11/30/22 Baird
- Apple estimates lowered due to ongoing assembly challenges, says Baird
- 11/29/22 Deutsche Bank
- Apple Pay taking e-commerce share from PayPal, says Deutsche Bank
- 11/28/22 Wedbush
- Apple iPhone shortages build into holiday season, says Wedbush
- 11/23/22 Morgan Stanley
- Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
- 10/31/22 Gordon Haskett
- Gordon Haskett wonders if 'more going on' as Fertitta takes stake in Wynn
- 10/21/22 Wedbush
- Twitter deal still 'brutal situation' for Tesla holders, Wedbush says
- 10/18/22 Gordon Haskett
- Bilson sees Tesla share sale coming with Musk $8B short for Twitter
- 11/22/22 Barclays
- Airbnb price target raised to $103 from $101 at Barclays
- 11/22/22 Baird
- Airbnb downgraded to Neutral from Outperform at Baird
- 11/17/22 Citi
- Airbnb supply growth should continue to ramp, says Citi
- 11/02/22 Evercore ISI
- Airbnb removed for 'TAP Outperform' list at Evercore ISI
- 10/31/22 Citi
- Pinterest price target raised to $26 from $25 at Citi
- 10/28/22 Stifel
- Pinterest 'a rare bright spot thus far through earnings,' says Stifel
- 10/28/22 Barclays
- Pinterest price target raised to $25 from $23 at Barclays
- 10/28/22 Piper Sandler
- Pinterest price target raised to $25 from $23 at Piper Sandler
- 11/28/22 Jefferies
- XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
- 11/28/22 Jefferies
- XPeng downgraded to Underperform from Hold at Jefferies
- 11/22/22 DBS Bank
- XPeng initiated with a Buy at DBS Bank (earlier)
- 11/17/22 UBS
- XPeng upgraded to Buy from Neutral at UBS
- 11/23/22 Morgan Stanley
- Baidu price target lowered to $120 from $140 at Morgan Stanley
- 11/23/22 Benchmark
- Baidu price target lowered to $200 from $270 at Benchmark
- 11/23/22 Mizuho
- Baidu price target lowered to $180 from $200 at Mizuho
- 11/23/22 Citi
- Baidu price target lowered to $166 from $169 at Citi
- 11/30/22 DA Davidson
- Solid Power cut to Neutral at DA Davidson on sudden announcement of CEO retiring
- 11/30/22 DA Davidson
- Solid Power downgraded to Neutral from Buy at DA Davidson
- 10/31/22 Cowen
- Solid Power initiated with a Market Perform at Cowen
- 06/29/22 Chardan
- Solid Power initiated with a Buy at Chardan
- 11/23/22 Deutsche Bank
- AST SpaceMobile price target raised to $32 from $30 at Deutsche Bank
- 10/28/22 B. Riley
- AST SpaceMobile initiated with a Buy at B. Riley
- 10/19/22 Barclays
- AST SpaceMobile price target lowered to $15 from $29 at Barclays
- 08/17/22 Deutsche Bank
- AST SpaceMobile price target lowered to $30 from $31 at Deutsche Bank
- 11/30/22 Stifel
- Micron management's tone 'incrementally downbeat,' says Stifel
- 11/29/22 Mizuho
- Micron price target lowered to $50 from $52 at Mizuho
- 11/17/22 UBS
- Micron price target lowered to $75 from $80 at UBS
- 11/16/22 Wedbush
- Wedbush keeps Outperform on Micron, says deterioration understood
- 11/30/22 Northland
- NetApp price target lowered to $99 from $101 at Northland
- 11/30/22 Wells Fargo
- NetApp price target lowered to $70 from $85 at Wells Fargo
- 11/30/22 Cowen
- NetApp price target lowered to $80 from $93 at Cowen
- 11/30/22 Wedbush
- NetApp price target lowered to $70 from $80 at Wedbush
- $160.55 /
+17.18 (+11.98%) - 11/30/22 Deutsche Bank
- Workday price target lowered to $215 from $230 at Deutsche Bank
- 11/30/22 Baird
- Workday price target lowered to $223 from $235 at Baird
- 11/30/22 JPMorgan
- Workday price target lowered to $223 from $235 at JPMorgan
- 11/30/22 Mizuho
- Workday price target lowered to $200 from $220 at Mizuho
- 11/28/22 Stifel
- Leslie's price target lowered to $17 from $20 at Stifel
- 11/15/22 Baird
- Leslie's downgraded to Neutral from Outperform at Baird
- 10/03/22 MKM Partners
- MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability
- 10/03/22 MKM Partners
- Leslie's initiated with a Neutral at MKM Partners
- $10.72 /
+1.245 (+13.14%) - 11/28/22 Wedbush
- Black Friday winners Include Best Buy, losers include Pets, says Wedbush
- 11/28/22 Needham
- Petco price target lowered to $20 from $30 at Needham
- 10/31/22 Citi
- Petco price target lowered to $15 from $19 at Citi
- 10/21/22 Jefferies
- Petco transferred with a Hold at Jefferies
- 11/30/22 Baird
- Cooper Companies upgraded to Outperform from Neutral at Baird
- 11/28/22 JPMorgan
- Cooper Companies price target raised to $330 from $300 at JPMorgan
- 11/03/22 Piper Sandler
- Cooper Companies price target lowered to $355 from $375 at Piper Sandler
- 10/11/22 Jefferies
- Cooper Companies downgraded to Hold from Buy at Jefferies
- 11/30/22 BofA
- BofA downgrades Carvana to Neutral on liquidity concerns
- 11/30/22 BofA
- Carvana downgraded to Neutral from Buy at BofA
- 11/22/22 Baird
- Carvana downgraded to Neutral from Outperform at Baird
- 11/21/22 Cowen
- Carvana downgraded to Market Perform from Outperform at Cowen
- 11/30/22
- XPeng sees Q4 revenue RMB 4.8B-RMB 5.1B
- 11/30/22
- XPeng reports Q3 EPS (36c), consensus (36c)
- 08/23/22
- XPeng sees Q3 revenue RMB6.8B-RMB7.2B, up 18.9%-25.9% from last year
- 08/23/22
- XPeng reports Q2 no-GAAP EPS (43c), consensus ($2.61)
- $10.72 /
+1.245 (+13.14%) - 11/30/22
- Petco cuts FY22 adjusted EPS view to 75c-79c from 77c-81, consensus 77c
- 11/30/22
- Petco reports Q3 adjusted EPS 16c, consensus 16c
- $160.55 /
+17.18 (+11.98%) - 11/29/22
- Workday raises low end of FY23 subscription revenue to $5.555B-$5.557B
- 11/29/22
- Workday reports Q3 adjusted EPS 99c, consensus 84c
- 08/25/22
- Workday still sees FY23 suscription revenue up 22% y-o-y to $5.54B-$5.56B
- 10/25/22
- UBS reports Q3 EPS 52c, net profit $1.7B
- 07/26/22
- UBS reports Q2 EPS 61c, net profit $2.108B
- 07/22/22
- Twitter reports Q2 EPS (8c), consensus 14c
- 07/21/22
- Notable companies reporting before tomorrow's open
- 10/28/22
- Sanofi now sees 2022 business EPS growing 16% at CER
- 10/28/22
- Sanofi reports Q3 business EPS EUR 2.88, up 17.9% at CER
- 07/28/22
- Sanofi sees 2022 business EPS growing 15% at CER
- 07/28/22
- Sanofi reports Q2 business EPS EUR 1.73, up 16.7% at CER
- 08/09/22
- Solid Power sees FY22 revenue at high end of $3M-$5M range, consensus $4.55M
- 08/09/22
- Solid Power reports Q2 EPS 8c, consensus (9c)
- 11/09/22
- Rivian Automotive reports Q3 adjusted EPS ($1.57), consensus ($1.82)
- 11/09/22
- Notable companies reporting after market close
- 10/27/22
- Amazon reports Q3 EPS 28c with Rivian gain, consensus 21c
- 08/11/22
- Rivian Automotive reports Q2 EPS ($1.89), consensus ($1.67)
- 10/27/22
- Pinterest sees Q4 revenue up mid single digits, consensus $884.57M
- 10/27/22
- Pinterest reports Q3 adjusted EPS 11c, consensus 6c
- 08/01/22
- Pinterest sees Q3 revenue growth mid-single digits, consensus $713.47M
- 11/29/22
- NetApp cuts FY23 EPS view to $5.30-$5.50 from $5.40-$5.60, consensus $5.52
- 11/29/22
- NetApp sees Q3 adjusted EPS $1.25-$1.35, consensus $1.44
- 11/29/22
- NetApp reports Q2 adjusted EPS $1.48, consensus $1.33
- 09/29/22
- Micron sees Q2 revenue range similar to Q1
- 09/29/22
- Micron sees Q1 adjusted EPS 4c, plus or minus 10c, consensus 64
- 09/29/22
- Micron reports Q4 adjusted EPS $1.45, consensus $1.30
- 09/29/22
- Notable companies reporting after market close
- 11/30/22
- Leslie's sees 2023 adjusted EPS 78c-86c, consensus 93c
- 11/30/22
- Leslie's reports Q4 adjusted EPS 35c, consensus 31c
- 11/08/22
- Lucid Group reports Q3 EPS (40c), consensus (31c)
- 11/08/22
- Notable companies reporting after market close
- 08/03/22
- Lucid Group reports Q2 EPS (33c), consensus (36c)
- 10/18/22
- Johnson & Johnson cuts FY22 estimated reported sales view to $93.0B-$93.5B
- 10/18/22
- Johnson & Johnson narrows FY22 adjusted operational EPS view to $10.70-$10.75
- 10/18/22
- Johnson & Johnson narrows FY22 adjusted EPS view to $10.02-$10.07
- 10/18/22
- Johnson & Johnson reports Q3 adjusted EPS $2.55, consensus $2.48
- $394.43 /
+13.31 (+3.49%) - 11/29/22
- Intuit sees Q2 adjusted EPS $1.41-$1.45, consensus $2.06
- 11/29/22
- Intuit backs FY23 adjusted EPS view $13.59-$13.89, consensus $13.75
- 11/29/22
- Intuit reports Q1 adjusted EPS $1.66, consensus $1.22
HZNP Horizon Therapeutics - $99.90 /
+21.15 (+26.86%) - 11/02/22
- Horizon Therapeutics sees FY22 revenue s $3.59B-$3.61B, consensus $3.56B
- 11/02/22
- Horizon Therapeutics reports Q3 EPS $1.25, consensus $1.01
- 08/03/22
- Horizon Therapeutics cuts FY22 revenue view to $3.53B-$3.6B from $3.9B-$4B
- 08/03/22
- Horizon Therapeutics reports Q2 adjusted EPS $1.07, consensus $1.35
- 11/30/22
- Hormel Foods sees FY23 EPS $1.83-$1.93, consensus $2.00
- 11/30/22
- Hormel Foods reports Q4 EPS 51c, consensus 50c
- 11/29/22
- Notable companies reporting before tomorrow's open
- 11/29/22
- HP Enterprise backs FY23 EPS view $1.96-$2.04, consensus $2.03
- 11/29/22
- HP Enterprise sees Q1 adjusted EPS 50c-58c, consensus 49c
- 11/29/22
- HP Enterprise reports Q4 adjusted EPS 57c, consensus 56c
- 11/02/22
- Fisker reports Q3 EPS (49c), consensus (43c)
- 08/03/22
- Fisker reports Q2 EPS (36c), consensus (41c)
- 08/03/22
- Notable companies reporting after market close
- 11/03/22
- Carvana sees sequential reduction in retail units sold in Q4
- 11/03/22
- Carvana reports Q3 EPS ($2.67), consensus ($1.94)
- 08/04/22
- Carvana reports Q2 EPS ($2.35), consensus ($1.79)
- $111.07 /
-27.11 (-19.62%) - 11/29/22
- Crowdstrike raises FY23 EPS view to $1.49-$1.52 from $1.31-$1.33
- 11/29/22
- Crowdstrike sees Q4 adjusted EPS 42c-45c, consensus 34c
- 11/29/22
- Crowdstrike reports Q3 adjusted EPS 40c, consensus 31c
- 11/29/22
- Notable companies reporting after market close
- 08/31/22
- Cooper Companies sees Q4 revenue $830M - $850M, consensus $841.43M
- 08/31/22
- Cooper Companies sees Q EPS12.72 - $12.87 , consensus $13.14
- 08/31/22
- Cooper Companies sees Q4 EPS $3.05-$3.20, consensus $3.42
- 08/31/22
- Cooper Companies reports Q3 EPS $3.19, consensus $3.23
- 11/22/22
- Baidu reports Q3 EPS $2.37, consensus $2.15
- 08/30/22
- Baidu reports Q2 EPS $2.36, consensus $1.63
- 08/29/22
- Notable companies reporting before tomorrow's open
- 11/30/22
- Build-A-Bear sees FY22 revenue $455M-$465M vs. $411.5M in FY21
- 11/30/22
- Build-A-Bear reports Q3 EPS 51c vs. 36c a year ago
- 08/15/22
- AST SpaceMobile reports Q2 EPS (6c) vs. (39c) last year
- 07/19/22
- American Resources reports preliminary Q2 revenue $16.2M vs. $393,210 last year
- 11/03/22
- Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00
- 11/03/22
- Amgen reports Q3 adjusted EPS $4.70, consensus $4.44
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.40
- 11/01/22
- Airbnb sees Q4 revenue $1.8B-$1.88B, consensus $1.85B
- 11/01/22
- Airbnb reports Q3 EPS $1.79, consensus $1.47
- 11/01/22
- Notable companies reporting after market close
- 08/02/22
- Airbnb sees Q3 revenue $2.78B-$2.88B, consensus $2.77B
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
- 07/28/22
- Apple reports Q3 EPS $1.20, consensus $1.16
- 07/28/22
- Notable companies reporting after market close
|
Conference/Events
|
Virtual Investor Day,… Virtual Investor Day, including 4Q and FY2022 earnings results, to be held on November 30 at 10 am. Webcast Link ShowHide Related Items >><< - 09/29/22
- Leslie's publishes annual ESG report
- 09/28/22
- Leslie's to replace GCP Applied Technologies in S&P 600 at open on 9/28
- 07/14/22
- Leslie's opened 11 new stores in summer 2022
- 11/28/22 Stifel
- Leslie's price target lowered to $17 from $20 at Stifel
- 11/15/22 Baird
- Leslie's downgraded to Neutral from Outperform at Baird
- 10/03/22 MKM Partners
- MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability
- 10/03/22 MKM Partners
- Leslie's initiated with a Neutral at MKM Partners
- 11/30/22
- Leslie's sees 2023 adjusted EPS 78c-86c, consensus 93c
- 11/30/22
- Leslie's reports Q4 adjusted EPS 35c, consensus 31c
- 11/29/22
- Notable companies reporting before tomorrow's open
|
On The Fly
|
Check out this morning's… ShowHide Related Items >><< - 11/15/22
- Cathie Wood's ARK Investment bought 105K shares of XPeng
- 11/07/22
- XPeng rises 9.7%
- 11/01/22
- XPeng obtains autonomous driving test for G9
- 11/01/22
- Xpeng delivers 5,101 Smart EVs in October
- 11/30/22
- Petco announces partnership with Stella & Chewy's
- 11/30/22
- Petco jumps 13% to $10.76 after Q3 results, FY22 guidance
- 11/30/22
- Petco reports Q3 comparable sales growth of 4.1%
- 10/27/22
- Petco, Nationwide announce multi-year partnership
- 11/29/22
- Workday sees FY24 subscription revenue growth of 17%-19% to $6.5B-$6.6B
- 11/29/22
- Workday jumps 5% to $150.00 after Q3 results beat estimates
- 11/29/22
- Workday reports Q3 subscription revenue $1.43B, up 22.3% y/y
- 11/29/22
- Workday announces $500M share repurchase program
- 09/30/22
- Titan Machinery announces appointment of Larsen as CFO
- 07/11/22
- Titan Machinery to acquire Heartland Ag Systems for $110M
- 11/30/22
- Sanofi reports Phase II/III study results for acoziborole published in Lancet
- 11/17/22
- Provention Bio's Tzield approved by FDA for diabetes
- 09/29/22
- Leslie's publishes annual ESG report
- 09/28/22
- Leslie's to replace GCP Applied Technologies in S&P 600 at open on 9/28
- 07/14/22
- Leslie's opened 11 new stores in summer 2022
- 11/30/22
- AC Immune's ACI-35.030 selected for further development
- 11/22/22
- BeiGene to present final PFS results from ALPINE trial at ASH 2022
HZNP Horizon Therapeutics - 11/29/22
- Horizon Therapeutics jumps 33% after deal talks with Amgen, Janssen, Sanofi
- 11/29/22
- Horizon Pharma trading resumes
- 11/29/22
- Horizon Therapeutics confirms preliminary deal talks with Amgen, Janssen, Sanofi
- 11/29/22
- Horizon Pharma trading halted, news pending
- 09/12/22
- Oneok names Janet Hogan as Chief Human Resources Officer
- 08/09/22
- Hormel Foods announces new operating model
- 09/28/22
- Synaptogenix 'welcomes' Lecanemab Phase 3 trial results
- 09/27/22
- Eisai jumps 17% in early Tokyo trading after lecanemab data
- 09/27/22
- Biogen/Eisai's phase 3 trial of lecanemab in MCI meet primary endpoint
- 11/30/22
- Enbridge, OLCV to develop CO2 sequestration hub in Texas Gulf Coast
- 11/30/22
- Enbridge expects to deploy approximately C$6B of capital in 2023
- 11/30/22
- Enbridge raises quarterly dividend 3.2% to C$0.8875 per share
- 10/03/22
- Enbridge CEO Al Monaco to retire, Greg Ebel to succeed
- 08/31/22
- Donaldson sees FY23 CapEx $115M-$135M
- 06/14/22
- Donaldson acquires Purilogics for $20M plus milestones
- 06/01/22
- Donaldson sees FY22 CapEx $90M-$100M
- 06/01/22
- Donaldson CEO sees Q4 'sequential sales and gross margin improvement'
- 11/29/22
- Crowdstrike sees Q4 ARR below Q3 levels by up to 10%
- 11/29/22
- Crowdstrike falls 18% after Q3 results and guidance
- 09/20/22
- Crowdstrike to acquire external attack surface management firm Reposify
- 09/14/22
- CrowdStrike Appoints Jennifer Johnson as CMO
- 11/29/22
- Eisai and Biogen present full results for Lecanemab phase 3 study in AD
- 11/10/22
- Biogen names Viehbacher president, CEO
- 10/17/22
- Biogen announces FDA's 3-month expansion of review filing for NDA for tofersen
- 10/17/22
- Sage Therapeutics and Biogen present Phase 3 zuranolone results in depression
- 09/28/22
- Build-A-Bear announces release of NFT collection
- 07/26/22
- Cannell Capital discloses 10.7% activist stake in Build-A-Bear
- 07/08/22
- Kanen Wealth urges Build-A-Bear to 'take transformative action immediately'
- 11/14/22
- Greenlight takes new stake in Intel, exits position in Atlas Air
- 11/14/22
- AST SpaceMobile deploys commercial communications array in low Earth orbit
- 10/26/22
- AST SpaceMobile announces BlueWalker 3 test satellite update, Q3 results
- 09/15/22
- AST SpaceMobile down 8% to $9.38 after Kerrisdale release short report
- 11/22/22
- FDA investigating risk of severe hypocalcemia in patients receiving Prolia
- 11/09/22
- Royalty Pharma agrees to acquire royalty interest in olpasiran from Arrowhead
- 11/30/22 Mizuho
- Mizuho says Biogen not mentioned in 90 minute lecanemab presentation
- 11/30/22 Jefferies
- Biogen price target raised to $350 from $325 at Jefferies
- 11/30/22 Wedbush
- Biogen price target raised to $247 from $218 at Wedbush
- 11/30/22 JPMorgan
- Biogen Alzheimer's data increases approval confidence, says JPMorgan
HZNP Horizon Therapeutics - 11/30/22 Cowen
- Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
- 11/30/22 Wells Fargo
- Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
- 11/01/22 H.C. Wainwright
- Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
- 10/25/22 Piper Sandler
- Horizon Therapeutics price target lowered to $88 from $90 at Piper Sandler
- 11/28/22 Wedbush
- Black Friday winners Include Best Buy, losers include Pets, says Wedbush
- 11/28/22 Needham
- Petco price target lowered to $20 from $30 at Needham
- 10/31/22 Citi
- Petco price target lowered to $15 from $19 at Citi
- 10/21/22 Jefferies
- Petco transferred with a Hold at Jefferies
- 08/25/22 Baird
- Titan Machinery price target raised to $34 from $27 at Baird
- 07/11/22 Baird
- Baird trims Titan Machinery price target to $27, but 'likes' Heartland Ag deal
- 05/27/22 Stephens
- Titan Machinery price target lowered to $41 from $44 at Stephens
- 05/26/22 Baird
- Titan Machinery price target raised to $32 from $30 at Baird
- 09/01/22 Baird
- Donaldson price target lowered to $59 from $61 at Baird
- 07/18/22 Stifel
- Donaldson price target lowered to $51 from $53 at Stifel
- 06/02/22 Baird
- Donaldson price target lowered to $61 from $65 at Baird
- 03/03/22 Baird
- Donaldson price target lowered to $65 from $70 at Baird
- 11/07/22 National Bank
- Enbridge downgraded to Sector Perform from Outperform at National Bank
- 10/20/22 Scotiabank
- Enbridge price target lowered to C$56 from C$62 at Scotiabank
- 10/19/22 Morgan Stanley
- Enbridge price target lowered to C$64 from C$67 at Morgan Stanley
- 09/12/22 Raymond James
- Enbridge upgraded to Outperform from Market Perform at Raymond James
- 11/28/22 Jefferies
- XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
- 11/28/22 Jefferies
- XPeng downgraded to Underperform from Hold at Jefferies
- 11/22/22 DBS Bank
- XPeng initiated with a Buy at DBS Bank (earlier)
- 11/17/22 UBS
- XPeng upgraded to Buy from Neutral at UBS
- 11/30/22 Deutsche Bank
- Workday price target lowered to $215 from $230 at Deutsche Bank
- 11/30/22 Baird
- Workday price target lowered to $223 from $235 at Baird
- 11/30/22 JPMorgan
- Workday price target lowered to $223 from $235 at JPMorgan
- 11/30/22 Mizuho
- Workday price target lowered to $200 from $220 at Mizuho
- 11/28/22 Stifel
- Leslie's price target lowered to $17 from $20 at Stifel
- 11/15/22 Baird
- Leslie's downgraded to Neutral from Outperform at Baird
- 10/03/22 MKM Partners
- MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability
- 10/03/22 MKM Partners
- Leslie's initiated with a Neutral at MKM Partners
- 09/22/22 Argus
- Hormel Foods price target lowered to $53 from $54 at Argus
- 09/02/22 Piper Sandler
- Hormel Foods price target lowered to $47 from $48 at Piper Sandler
- 08/23/22 Stephens
- Hormel Foods price target raised to $55 from $50 at Stephens
- 03/15/22 Goldman Sachs
- Hormel Foods downgraded to Sell from Neutral at Goldman Sachs
- 11/30/22 Needham
- Crowdstrike price target lowered to $165 from $225 at Needham
- 11/30/22 DA Davidson
- Crowdstrike price target lowered to $145 from $235 at DA Davidson
- 11/30/22 MKM Partners
- Crowdstrike price target lowered to $190 from $200 at MKM Partners
- 11/30/22 Morgan Stanley
- Morgan Stanley says investors should 'buy the dip' in Crowdstrike after Q3
- 11/23/22 Deutsche Bank
- AST SpaceMobile price target raised to $32 from $30 at Deutsche Bank
- 10/28/22 B. Riley
- AST SpaceMobile initiated with a Buy at B. Riley
- 10/19/22 Barclays
- AST SpaceMobile price target lowered to $15 from $29 at Barclays
- 08/17/22 Deutsche Bank
- AST SpaceMobile price target lowered to $30 from $31 at Deutsche Bank
- 11/29/22 Craig-Hallum
- Craig-Hallum sees potential for competing Apollo Endosurgery bids
- 11/28/22 Morgan Stanley
- Genmab risk/reward favorable into arbitration ruling, says Morgan Stanley
- 11/17/22 Credit Suisse
- Johnson & Johnson initiated with a Neutral at Credit Suisse
- 11/17/22 Credit Suisse
- Amgen initiated with an Underperform at Credit Suisse
- 11/08/22 Oppenheimer
- Amgen price target raised to $300 from $290 at Oppenheimer
- 11/08/22 Truist
- Amgen price target raised to $280 from $266 at Truist
- 11/14/22 Oppenheimer
- Biogen price target raised to $315 from $300 at Oppenheimer
- 10/14/22 Barclays
- Sanofi price target lowered to EUR 85 from EUR 105 at Barclays
- 10/06/22 Jefferies
- Provention Bio price target raised to $15 from $10 at Jefferies
- 11/29/22 Jefferies
- Prothena data from AD/PD abstract 'promising,' says Jefferies
- 11/14/22 Jefferies
- Biogen scarcity value goes up after Roche miss in Alzheimer's, says Jefferies
- 11/30/22
- XPeng sees Q4 revenue RMB 4.8B-RMB 5.1B
- 11/30/22
- XPeng reports Q3 EPS (36c), consensus (36c)
- 08/23/22
- XPeng sees Q3 revenue RMB6.8B-RMB7.2B, up 18.9%-25.9% from last year
- 08/23/22
- XPeng reports Q2 no-GAAP EPS (43c), consensus ($2.61)
- 11/30/22
- Petco cuts FY22 adjusted EPS view to 75c-79c from 77c-81, consensus 77c
- 11/30/22
- Petco reports Q3 adjusted EPS 16c, consensus 16c
- 11/29/22
- Notable companies reporting before tomorrow's open
- 11/29/22
- Workday raises low end of FY23 subscription revenue to $5.555B-$5.557B
- 11/29/22
- Workday reports Q3 adjusted EPS 99c, consensus 84c
- 11/29/22
- Notable companies reporting after market close
- 08/25/22
- Workday still sees FY23 suscription revenue up 22% y-o-y to $5.54B-$5.56B
- 11/30/22
- Titan Machinery raises FY23 EPS view to $4.55-$4.85 from $3.70-$4.00
- 11/30/22
- Titan Machinery reports Q3 EPS $1.82, consensus $1.16
- 08/25/22
- Titan Machinery raises FY23 EPS view to $3.70-$4.00 from $2.90-$3.20
- 08/25/22
- Titan Machinery reports Q2 adjusted EPS $1.10 vs. 53c a year ago
- 10/28/22
- Sanofi now sees 2022 business EPS growing 16% at CER
- 10/28/22
- Sanofi reports Q3 business EPS EUR 2.88, up 17.9% at CER
- 07/28/22
- Sanofi sees 2022 business EPS growing 15% at CER
- 07/28/22
- Sanofi reports Q2 business EPS EUR 1.73, up 16.7% at CER
- 11/30/22
- Leslie's sees 2023 adjusted EPS 78c-86c, consensus 93c
- 11/30/22
- Leslie's reports Q4 adjusted EPS 35c, consensus 31c
- 10/18/22
- Johnson & Johnson cuts FY22 estimated reported sales view to $93.0B-$93.5B
- 10/18/22
- Johnson & Johnson narrows FY22 adjusted operational EPS view to $10.70-$10.75
- 10/18/22
- Johnson & Johnson narrows FY22 adjusted EPS view to $10.02-$10.07
- 10/18/22
- Johnson & Johnson reports Q3 adjusted EPS $2.55, consensus $2.48
HZNP Horizon Therapeutics - 11/02/22
- Horizon Therapeutics sees FY22 revenue s $3.59B-$3.61B, consensus $3.56B
- 11/02/22
- Horizon Therapeutics reports Q3 EPS $1.25, consensus $1.01
- 08/03/22
- Horizon Therapeutics cuts FY22 revenue view to $3.53B-$3.6B from $3.9B-$4B
- 08/03/22
- Horizon Therapeutics reports Q2 adjusted EPS $1.07, consensus $1.35
- 11/30/22
- Hormel Foods reports Q4 EPS 51c, consensus 50c
- 11/30/22
- Enbridge sees FY23 EBITDA C$15.9B-C$16.5B, DCF C$5.25-C$5.65
- 11/30/22
- Enbridge backs FY22 adjusted EBITDA view in 'top half' of C$15B-C$15.6B
- 11/04/22
- Enbridge backs FY22 EBITDA view C$15B-C$15.6B
- 11/04/22
- Enbridge reports Q3 adjusted EPS C$0.67 vs. C$0.59 a year ago
- 11/30/22
- Donaldson sees FY23 adjusted EPS $2.91-$3.07, consensus $2.92
- 11/30/22
- Donaldson reports Q1 adjusted EPS 75c, consensus 71c
- 08/31/22
- Donaldson sees FY23 EPS $2.91-$3.07 , consensus $3.03
- 08/31/22
- Donaldson reports Q4 adjusted EPS 84c, consensus 84c
- 11/29/22
- Crowdstrike raises FY23 EPS view to $1.49-$1.52 from $1.31-$1.33
- 11/29/22
- Crowdstrike sees Q4 adjusted EPS 42c-45c, consensus 34c
- 11/29/22
- Crowdstrike reports Q3 adjusted EPS 40c, consensus 31c
- 10/25/22
- Biogen raises FY22 EPS view to $16.50-$17.15, consensus $16.49
- 10/25/22
- Biogen reports Q3 adjusted EPS $4.77, consensus $4.15
- 10/24/22
- Notable companies reporting before tomorrow's open
- 11/30/22
- Build-A-Bear sees FY22 revenue $455M-$465M vs. $411.5M in FY21
- 11/30/22
- Build-A-Bear reports Q3 EPS 51c vs. 36c a year ago
- 08/15/22
- AST SpaceMobile reports Q2 EPS (6c) vs. (39c) last year
- 11/03/22
- Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00
- 11/03/22
- Amgen reports Q3 adjusted EPS $4.70, consensus $4.44
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.40
|
Earnings
|
Sees 2023 revenue… Sees 2023 revenue $1.56B-$1.64B, consensus $1.56B. ShowHide Related Items >><< - 09/29/22
- Leslie's publishes annual ESG report
- 09/28/22
- Leslie's to replace GCP Applied Technologies in S&P 600 at open on 9/28
- 07/14/22
- Leslie's opened 11 new stores in summer 2022
- 11/28/22 Stifel
- Leslie's price target lowered to $17 from $20 at Stifel
- 11/15/22 Baird
- Leslie's downgraded to Neutral from Outperform at Baird
- 10/03/22 MKM Partners
- MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability
- 10/03/22 MKM Partners
- Leslie's initiated with a Neutral at MKM Partners
- 11/30/22
- Leslie's reports Q4 adjusted EPS 35c, consensus 31c
- 11/29/22
- Notable companies reporting before tomorrow's open
- 08/05/22
- Leslie's cuts FY22 adjusted EPS view to 90c-96c from $1.02-$1.10
|
Earnings
|
Reports Q4 revenue… Reports Q4 revenue $475.6M, consensus $470.44M. Mike Egeck, Chief Executive Officer, commented, "We are pleased to close out the year on a strong note with 16.3% sales growth, a 30.1% increase in net income, and a 21.3% increase in Adjusted EBITDA for the fourth quarter. This performance was enabled by the outstanding work of our supply chain team driving strong DC performance in the quarter. For the full year, execution of our strategic growth initiatives resulted in record sales, gross profit and Adjusted EBITDA, as well as market share gains. Looking ahead, while we anticipate a challenging macro-economic backdrop for Fiscal 2023, we remain focused on delivering against our long-term objectives supported by the recurring non-discretionary demand of the aftermarket pool industry, the competitive advantages of our integrated network of physical and digital assets and the execution of our strategic growth initiatives," Mr. Egeck concluded. ShowHide Related Items >><< - 09/29/22
- Leslie's publishes annual ESG report
- 09/28/22
- Leslie's to replace GCP Applied Technologies in S&P 600 at open on 9/28
- 07/14/22
- Leslie's opened 11 new stores in summer 2022
- 11/28/22 Stifel
- Leslie's price target lowered to $17 from $20 at Stifel
- 11/15/22 Baird
- Leslie's downgraded to Neutral from Outperform at Baird
- 10/03/22 MKM Partners
- MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability
- 10/03/22 MKM Partners
- Leslie's initiated with a Neutral at MKM Partners
- 11/29/22
- Notable companies reporting before tomorrow's open
- 08/05/22
- Leslie's cuts FY22 adjusted EPS view to 90c-96c from $1.02-$1.10
- 08/05/22
- Leslie's reports Q3 adjusted EPS 68c, consensus 74c
|